Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis

Studies comparing the effects of natalizumab and fingolimod in relapsing–remitting multiple sclerosis (RRMS) are limited. We aimed to compare natalizumab and fingolimod effects on clinical, neuropsychological, and MRI measures in RRMS patients after 2 years of treatment. RRMS patients starting natal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotherapeutics
Hauptverfasser: Preziosa, Paolo, Rocca, Maria A., Riccitelli, Gianna C., Moiola, Lucia, Storelli, Loredana, Rodegher, Mariaemma, Comi, Giancarlo, Signori, Alessio, Falini, Andrea, Filippi, Massimo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007466/
https://ncbi.nlm.nih.gov/pubmed/31452082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00781-w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge